Colgate-Palmolive Company (NYSE:CL) is included among the The 11 Best Rising Dividend Stocks to Buy Right Now.
On May 5, Barclays raised its price recommendation for Colgate-Palmolive Company (NYSE:CL) to $80 from $79. He reiterated an equal weight rating on the stock. The firm said it believes it is focusing on achieving a better balance between pricing and volume growth in 2026.
A few days earlier, on May 2, Goldman Sachs raised its price target for Colgate-Palmolive from $98 to $100. He maintained a Buy rating on the stock. The firm highlighted better-than-expected first quarter results, with revenue and profits above expectations. According to the analyst, organic sales growth was stronger than expected, while broad-based strength across the business also supported slightly better-than-expected gross margins. Goldman Sachs added that EBIT margins remained in line with expectations even as advertising spending rose 10% during the quarter.
Colgate-Palmolive Company (NYSE:CL) focuses on oral care, personal care, home care and pet nutrition products.
While we recognize CL’s potential as an investment, we believe certain AI stocks offer greater growth potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that’s also benefiting significantly from Trump-era tariffs and the offshoring trend, check out our free report on best short-term AI stock.
READ NEXT: 12 Best Microcap Dividend Stocks to Buy Now and 10 Best Stocks to Buy Now for a $1 Million Portfolio
Disclosure: None. Follow Insider Monkey on Google News.